Published in
American Association for the Advancement of Science, Science Translational Medicine, 537(12), 2020
DOI: 10.1126/scitranslmed.aaz3577
Links
Tools
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer
Journal article published in 2020 by
Sumit K. Subudhi 
,
Luis Vence ,
Hao Zhao ,
Jorge Blando,
Shalini S. Yadav,
Qing Xiong,
Alexandre Reuben ,
Ana Aparicio ,
Paul G. Corn ,
Louis L. Pisters,
Brian F. Chapin,
Patricia Troncoso,
Rebecca Slack Tidwell ,
Peter Thall,
Chang-Jiun Wu
and other authors.
,
Luis Vence ,
Hao Zhao ,
Jorge Blando,
Shalini S. Yadav,
Qing Xiong,
Alexandre Reuben ,
Ana Aparicio ,
Paul G. Corn ,
Louis L. Pisters,
Brian F. Chapin,
Patricia Troncoso,
Rebecca Slack Tidwell ,
Peter Thall,
Chang-Jiun Wu
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Low–tumor mutational burden prostate tumors express neoantigens that elicit T cell responses associated with favorable clinical outcomes to ipilimumab.